NeurAxis, Inc. NRXS
6.86 USD +0.28 (+4.26%)
At closeNov 4, 2026, 7:43 PM EST
6.76 -0.10 -1.46%
After hours · Nov 4, 7:43 PM ET
6.51 Day range 6.87
2.31 52-week range 8.81
- YTD
- +51.10%
- 1 year
- +170.08%
Financial health
Altman Z-Score
4.88 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -4.8×
FY 2020 5y median -4.8× FY 2025
P/S 11.6×
FY 2020 5y median 11.6× FY 2025
P/B 12.1×
FY 2020 5y median -9.1× FY 2025
P/FCF -6.4×
FY 2020 5y median -6.4× FY 2025
EV/EBITDA -4.8×
FY 2020 5y median -4.8× FY 2025
EV/Sales 10.3×
FY 2020 5y median 10.3× FY 2025
FCF Yield -15.7%
FY 2020 5y median -15.7% FY 2025
Profitability
Gross Margin 84.2%
FY 2020 5y median 86.5% FY 2025
Operating Margin -219.4%
FY 2020 5y median -219.4% FY 2025
Net Margin -218.5%
FY 2020 5y median -218.5% FY 2025
ROE -229.5%
FY 2020 5y median 85.8% FY 2025
ROIC -204.7%
FY 2020 5y median 67.8% FY 2025
ROA -121.8%
FY 2020 5y median -322.8% FY 2025
Growth (YoY)
Revenue 32.9%
FY 2020 FY 2025
Operating Income -9.4%
FY 2020 FY 2025
EPS (diluted) 22.1%
FY 2020 FY 2025
Free Cash Flow -5.5%
FY 2020 FY 2025
Financial Health
Current Ratio 2.1×
FY 2020 5y median 0.3× FY 2025
Quick Ratio 2.0×
FY 2020 5y median 0.3× FY 2025
Debt / Equity 0.1×
FY 2020 5y median -0.1× FY 2025
Net Debt / EBITDA 0.6×
FY 2020 5y median -0.0× FY 2025
Interest Coverage -106×
FY 2020 5y median -23.8× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31